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Background: Opportunistic and non-opportunistic intestinal parasites play a significant role in the morbidity and mortality 
of HIV/AIDS-infected patients. The frequency of their occurrence strongly correlates with the patient’s level of immunity. 
The most common clinical manifestation of these intestinal parasites is diarrhoea. Prevalence of intestinal parasites among 
HIV-infected patients has been found to be as high as 95%.
Objective: To determine the prevalence of intestinal parasites among HIV-infected participants presenting with diarrhoea 
and association with CD4 cell counts, ART and cotrimoxazole prophylaxis.
Methods: A prospective cross-sectional study was conducted in four HIV clinics in Moshi district, Kilimanjaro Region, 
Tanzania. Stool samples were collected and analyzed from participants presenting with three or more episodes of loose stool 
per day or a single bloody bowel movement. The identification of parasites was done using direct microscopy and staining 
techniques. Demographic data, CD4 counts and stool results were recorded. Data analysis was done using STATA IC/11.1.
Results: The study included 83 adult HIV positive patients. There were 36 males (43.4%) and 47 females (56.6%), with a 
median age of 36 years (range 30-43). The baseline CD4 count was 150 cells/ul (range 72-295 cells/ul). Of our participants, 
47 (56.6%) had a baseline CD4 cell count < 200 cell/uL. Only 6(7.2%) had CD4 counts above 500cells/uL. Of the whole group, 
62(74.7%) were on ARV therapy and 33(39.8%) were on cotrimoxazole prophylaxis. Intestinal parasites were detected in 
25 of our participants. Among these 25 participants, Ascaris lumbricoides was found in 52%, Giardia lamblia in 32% and 
Entamoeba histolytica in 16%. The frequency of intestinal parasites was significantly associated with CD4 cell counts <200 
cells/ul (p=0.02). There was no significant difference in parasitic infections associated with ART status or cotrimoxazole use.
Conclusion: The prevalence of parasitic infection is high in HIV-infected patients presenting with diarrhoea despite the use 
of ART and other prophylactic medications. Intestinal parasites should not be overlooked in HIV-infected patients presenting 
with diarrhoea.
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Introduction
HIV/AIDS remains a major public health concern in sub-
Saharan Africa [1]. The prevalence in Tanzania is 5.1% 
in the 15-49 year age group 30 years into the epidemic 
[2]. Intestinal parasites are endemic in many regions of  
high HIV/AIDS prevalence [3] including in sub-Saharan 
Africa [4, 5]. Diarrhoea is reported to occur in 30-60% of  
HIV/AIDS patients in developed countries, and in up to 
90% of  patients in developing countries [6, 7]. 
Intestinal parasitic infections in HIV-infected patients in 
developing countries is estimated to be as high as 95%. 
These protozoal and helminthic infections often present 
with diarrhoea as their main feature [8]. Clinically these 
intestinal parasitic infections present as both acute and 
chronic diarrhoea contributing to significant morbidity and 
mortality in HIV-infected individuals. The epidemiology 
and outcome of  intestinal parasitic infections has been 
greatly affected by HIV infection [9]. 
Tanzania has high rates of  HIV and parasitic co-infections. 
However, there are few reports on the association of  
intestinal parasites in HIV-infected individuals with the 
level of  immunosuppression. The aim of  this study 
is to assess the prevalence of  opportunistic and non-
opportunistic intestinal parasitic infections among HIV-
infected patients presenting with diarrhoea, including the 
effect of  ART and immunosuppression.
Methods
Study design, setting and participants 





Age (years) 36 (30-43)
Sex                    
Male 36 (43.4%)
Female 47 (56.6%)
Education               
No formal education 5 (6.0%)
Primary 51 (61.4%)
Secondary 25 (30.1%)
Higher learning 2 (2.4%)
ART Use                  
Yes 62 (74.7%)
No 21 (25.3%)
Baseline CD4 (cells/ul) 150 (72-295)
Cotrimoxazole prophylaxis:  
Yes 33 (39.8%)
No 50 (60.2%)
Table 1. Socio-demographic characteristics of 83 HIV-
infected patients with diarrhoea attending HIV clinics in 
Moshi district, Kilimanjaro region
This prospective cross-sectional study was conducted at 
four HIV clinics in the Kilimanjaro Region of  Tanzania 
from August to October 2013. The study included 83 adult 
HIV positive patients aged 18 years and above presenting 
with three or more episodes of  loose stools per day or 
a single episode of  bloody bowel movement. Patients 
were excluded if  they had received any antiprotozoal or 
antihelminthic medications within the past one-month 
prior to screening for the study.
Data collection and analysis
Stool samples were collected using a clean wide mouthed 
container. The samples were then transferred to labeled, 
leak proof, clean and sterile plastic containers. All of  
the collected samples were examined within 2 hours of  
collection. A direct wet mount of  the stool sample was 
prepared and examined for the presence of  motile intestinal 
parasites and trophozoites under a light microscope. For 
the detection of  cysts, Lugol’s iodine staining was used. 
The microscopic examinations were performed by trained 
clinical laboratory technicians. Patients’ demographic 
data, baseline and maximum CD4 cell counts and stool 
results were recorded on a data collection sheet. The CD4 
counts were measured using a FACS count system (BD 
Biosciences, San Jose, CA, US). Data analysis was done 
using the computer software STATA IC/11.1 (College 
station, Texas).
Ethical consideration
Approval for the study was obtained from the University 
of  Dodoma Ethics Review Board, Moshi District 
Medical Officer (DMO) and Mawenzi Regional Hospital 
Authorities. Also an informed consent was obtained from 
all patients before their participation in the study. All 
patients found to have intestinal parasites were managed 
by clinicians according to available guidelines.
Results
The study included 83 adult HIV positive patients. Of  
these 36 (43.4%) were male and 47 (56.6%) female, with 
a combined median age (range) of  36 (30-43) years. 
Among the study participants, 62 (74.7%) were on ART 
and 21(25.3%) were not on ART; 33(39.8%) were on 
co-trimoxazole prophylaxis, while 50 (60.2%) were not 
on co-trimoxazole. The educational level of  the study 
group was 6.0% (no formal education), 61.4% (primary 
education) and 30.1% (secondary education). Baseline 
clinical and socio-demographic characteristics of  the 
study participants are summarized in Table 1.
Stool examination revealed intestinal parasites in 
25(30.1%) study participants; out of  whom 7(28%) 
were on cotrimoxazole and 20(80%) were on ART. The 
parasites found were of  three species; Entamoeba histolytica, 
Parasites HIV+ with diarrhoea
On ART (n=62) Not on ART     (n=21) On CTX(n=33) Not on CTX(n=50)
Entamoeba histolytica 2 (3.2%) 2 (9.5%) 2(6.1%) 2(4.0%)
Giardia lamblia 6 (9.7%) 2 (9.5%) 2(6.1%) 6(12%)
Ascaris lumbricoides 12 (19.4%) 1 (4.8%) 3(9.1%) 10(20%)
Stool negative 42 (67.7%) 16 (76.2%) 26(78.8%) 32(64%)
Table 2. Prevalence of intestinal parasites in 83 HIV-infected patients with diarrhoea attending HIV clinic in Moshi district, 
Kilimanjaro region by ART and cotrimoxazole status
*CTX: Cotrimoxazole
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Giardia lamblia and Ascaris lumbricoides.  Ascaris lumbricoides 
was the most frequent being found in 13(52%) participants 
of  whom 12 were on ART. Giardia lamblia was found 
positive in 8(32%) participants, 6 of  whom were on ART. 
Entamoeba histolytica was found in 4(16%) participants, 2 
of  whom were on ART. Out of  the 62 patients who were 
using ART, 42(67.7%) were not found to have intestinal 
parasites as summarized in   Table 2.
Among the 25 participants with intestinal parasites (see 
table 3), 19(76%) had CD4 count of  <200 cells/ul. Each 
individual parasite was significantly associated with CD4 
counts <200 cells/ul as compared to CD4 counts >200 
(p=0.02). Cotrimoxazole use was found to be protective 
against occurrence of  intestinal parasites, although the 
association was not statistically significant (OR=0.48 
[IQR 0.17-1.32], p=0.16).   
Discussion
The main finding from this study is the high prevalence 
of  intestinal parasites despite ART use and cotrimoxazole 
prophylaxis in this group of  HIV-infected patients 
presenting with diarrhoea. In HIV-infected patients, 
the immune response is significantly impaired resulting 
in susceptibility to gastrointestinal parasitic infections, 
a significant cause of  morbidity and mortality in this 
population. A majority of  these patients present with 
diarrhoea which can serve as an indicator of  disease 
progression. In our study, non-opportunistic parasites 
were found to be common. The prevalence of  intestinal 
parasites in this study was found to be 30%. This finding 
was consistent with another study done in Jaipur city [7], 
whereby non-opportunistic parasites were also found to 
be common with a prevalence of  31%. The prevalence 
was even higher in another study in Dhule district, India, 
at 49% [10]. Other studies, assessing both opportunistic 
and non-opportunistic intestinal parasites, have reported 
a prevalence of  non-opportunistic parasites ranging from 
5-30% [11] and 30-60% [12, 13, 14]. The occurrence of  
these parasites was significantly associated with low CD4 
counts (<200 cells/ul). Similarly in a study done in Benin 
City, Nigeria the occurrence of  intestinal parasites was 
significantly associated with CD4 counts <200 cells/ul 
[15]. In other studies however, only opportunistic parasites 
have been associated with low CD4 counts [7]. The 
association between the occurrence of  intestinal parasites 
and the level of  immunity in HIV-infected individuals has 
been well documented in other reports [16, 11, 17, 18]. 
Our study showed that there was no significant difference 
between the prevalence of  intestinal parasites in those on 
ART compared to those not on ART. This is in contrast 
to the findings of  a study done in Ethiopia which found 
significantly lower rates of  intestinal parasitic infection 
in those on ART [19]. Another study comparing the 
prevalence of  intestinal parasites before and after HAART 
found significant reductions in the prevalence of  intestinal 
parasites with the use of  ART [20]. These observed 
discrepancies might be explained by the difference in study 
sample sizes, study designs and geographic locations.
In our study, three of  the participants with CD4 counts 
>500 were found to have intestinal parasites. One of  them 
was found to have Giardia lamblia, while two of  them had 
Ascaris lumbricoides. Similar findings were obtained in a 
study done in Thailand were three of  the patients with CD4 
cell counts >500 were found to have non-opportunistic 
intestinal parasites [21]. Ascaris lumbricoides occurrence 
was also found to be high in seronegative individuals in 
one study comparing intestinal parasites in seronegative 
and seropositive individuals [22]. One study found no 
intestinal parasites in HIV-infected individuals with CD4 
count >500 cells/ul [7, 18] contrary to our finding.
Our study involved HIV-infected patients treated or 
untreated with ART presenting with diarrhoea. Other 
studies found higher prevalence of  opportunistic parasites 
in patients with diarrhoea [21], with similar rates of  non-
opportunistic parasites as found in our study [7]. Another 
study found high prevalence of  non-opportunistic 
parasites that was neither associated with the level of  
immunity nor with diarrhoea [21].
A limitation of  our study is that some important 
laboratory tests were not performed. We did not perform 
modified ZN-staining, water-ether sedimentation 
method or adhesive tape/anal swab for Microsporidia 
and Enterobius vermicularis respectively, as well as the 
Baerman technique or culture for Strongyloides stercoralis. 
Some important intestinal parasites, both opportunistic 
and non-opportunistic, could have therefore been missed. 
Other risk factors for acquisition of  intestinal parasites 
such as hygiene, socio-economic and environmental 







<200 4 (21%) 6 (31.6%) 9 (47.4%) 19 (76%)
>200 0 2 (33.3%) 4 (66.7%) 6 (24%) 0.02
Table 3. Prevalence of intestinal parasites by CD4 cell counts among 83 HIV-infected patients with diarrhoea attending 
HIV clinics in Moshi district, Kilimanjaro region
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factors were not included in this study. The sample size 
for this study was too small to make significant statistical 
inferences.
Non-opportunistic intestinal parasites were common 
in this population and significantly associated with low 
CD4 cell count. These infections therefore should not be 
overlooked in HIV-infected patients especially those with 
low CD4 counts and presenting with diarrhoea.
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INtErNAtIoNAL ENgLISH LANguAgE tEStINg SyStEM (IELtS) 
courSE IN JuBA
The first of  a number of  courses to prepare South Sudanese Doctors wishing to undertake postgraduate studies in 
various branches of  Medicine in the UK through the Medical Training Initiative (MTI) is intended to be held in Juba 
from 21st September to 2nd October 2015 inclusive pending confirmation of  funding.
Any Doctor committed to taking the IELTS examination in the near future who wishes to improve their IELTS 
scores may register for the course by emailing: Professor Mairi  John Blackings, Department of  English Language 
and Literature, University of  Juba at the following email: mairijb@yahoo.co.uk and  Telephone number +211 
955258192.
Places on the course will be allocated on a first come first served basis as these are limited to 20 only. Once the course 
is confirmed, the first 20 applicants will be contacted to confirm their place. There will be a booking fee of  SSP 350; 
failure to pay the fee will result in the place being offered to another candidate. 
Thank you.
Dr. Eluzai Hakim, MB.Ch.B, FRCP (Edin), FRCP (London), DTM&H
Consultant Physician & International Adviser to the Royal College of  Physicians London on South 
